Chembio Diagnostics Total Assets

Chembio Diagnostics posts a total assets of $63M as of December 2022. That compares with $73M in the prior-year period — down 14.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Chembio Diagnostics's total assets was $73M. The latest reading is $63M — a 14.5% year-over-year decrease (period ending December 2022). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of Chembio Diagnostics's financial statement story. At $63M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CEMI's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Chembio Diagnostics's other metric pages and overview cover the third.

Judging Chembio Diagnostics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in total assets easier to interpret. Start with $63M here, then scan peer and history charts to see if the gap is persistent.